Search results

Self‐injurious behaviour can become an intransigent difficulty, reduce people's quality of life and lead to hospital admissions or other restrictive outcomes (such as the wearing of protective devices to prevent serious injury). Over the last 15 years there have been some important developments in the treatment of severe self‐injury, but the evidence is that these are making little impact on most people's lives. The reasons why this might be are discussed, and it is proposed that it is time for a radical new approach to interventions for self‐injurious behaviour.

There are several infectious agents in the environment that can cause persistent infections in the host. They usually cause their symptoms shortly after first infection and later persist as silent viruses and bacteria within the body. However, these chronic infections may play an important role in the pathogenesis of schizophrenia and Tourette's syndrome (TS). We investigated the distribution of different neurotrophic infectious agents in TS, schizophrenia and controls. A total of 93 individuals were included (schizophrenic patients, Tourette patients and controls). We evaluated antibodies against cytomegalovirus (CMV), herpes-simplex virus (HSV), Epstein-Barr virus, Toxoplasma, Mycoplasma and Chlamydia trachomatis/pneumoniae. By comparing schizophrenia and TS, we found a higher prevalence of HSV (P=0.017) and CMV (P=0.017) antibodies in schizophrenic patients. Considering the relationship between schizophrenia, TS and healthy controls, we showed that there are associations for Chlamydia trachomatis (P=0.007), HSV (P=0.027) and CMV (P=0.029). When all measured viruses, bacteria and protozoa were combined, schizophrenic patients had a higher rate of antibodies to infectious agents than TS patients (P=0.049). Tourette and schizophrenic patients show a different vulnerability to infectious agents. Schizophrenic patients were found to have a higher susceptibility to viral infections than individuals with TS. This finding might point to a modification in special immune parameters in these diseases.

The involvement of people with learning disabilities with the police has long been a source of difficulty. This article first sets the scene by exploring the particular difficulties that different groups may have in their potential dealings with the police, including people with: autism spectrum disorders; attention deficit hyperactivity disorder (ADHD); cerebral palsy; Tourette's syndrome; and those with brain injury. The article then goes on to explore the particular experiences of brain‐injured children1 and their parents when the former are taken into police custody, based upon research conducted for an MPhil degree. This research sheds light onto a highly under‐researched area and aims to bring about change in the training of police officers with specific regard to disabilities resulting from brain injury. A total of 13 parents and eight police forces were interviewed and the research findings highlight the need for better education and training to address the multiplicity of problems that the police are called upon to deal with.

Atomoxetine has been approved for the treatment of attention deficit/hyperactivity disorder in both adults and children. However, it is also being examined for several off-label uses in adults including mood disorders, eating disorders, cognitive dysfunction, and the treatment of addictions. Prior to such use it is important to examine the reported adverse events to see if this represents an appropriate level of risk. This is particularly important in the light of recent warnings from several regulatory bodies about an increase in blood pressure in a significant percentage of patients taking atomoxetine. To understand the risks a literature review was performed, and which identified the following potential problems. The first is that this drug should not be given in patients with known cardiovascular problems, and that all adult patients who receive atomoxetine should be monitored for changes in blood pressure throughout treatment. Secondly, there are several clinical situations in which atomoxetine should be closely monitored, or avoided, including patients who have a history or risk of narrow angle glaucoma, epileptic seizures, Tourette's syndrome, a history of urinary outflow obstruction, or who are pregnant or lactating. In conclusion, the current literature suggests that atomoxetine can be safely used off-label provided the above precautions are taken.

Should those of us who are neurologically atypical be diagnosed as ill, so in need of treatment or cure, or accepted as embodying a different way of being, as called for by the neurodiversity movement? We consider what legal structures and health and social care systems would be appropriate to promote neurodiversity, and how far this infrastructure in the United Kingdom today meets these criteria for those diagnosed with cognitive disability and learning disability.

The general public and professionals from a range of backgrounds have increasingly become interested in autism spectrum disorders. This interest is particularly relevant to learning disability practitioners. Both autism and learning disabilities are independently associated with increased risk of mental health problems. Thus, when a person has learning disabilities and an autism spectrum disorder, a comprehensive assessment for mental health problems is of paramount importance. This paper provides an overview of the assessment of mental health problems in adults and children with neurodevelopmental disorders. The general assessment principles are outlined followed by assessment issues related to specific conditions such as psychoses, mood disorders and attention deficit hyperactivity disorder. Finally conclusions on the clinical implications are drawn.

Sleep disorders are extremely common in children and young people, and even more so in those with developmental disabilities. This client subgroup may prove refractory to standard behavioural and other psychosocial interventions that usually help and it is frequent for clinicians to resort to medication approaches given the high levels of personal and family distress that result. There is a need not only for further well structured research in this field but also for efforts to tackle the frequent relative neglect by clinicians of more researched and considered approaches. This review examines these issues selectively, focusing on important clinical issues and predicaments, and attempts a start at an evidence‐based background for practical and rational prescribing in this area of common childhood psychopathology.

The purpose of this paper is to review the empirical literature informing the nature of the relationship between criminal behaviour and both Alexithymia and Asperger's syndrome (AS).

The relevant literature was identified through database searches and via citations in primary sources.

Alexithymia and AS are relatively similar constructs with some overlap in their defining characteristics including utilitarian thinking and deficiencies in empathy. Alexithymia is significantly more prevalent in offender populations than controls and, in particular, has a complex relationship with psychopathy. The research concerning AS has mainly focused on offense type and reasons for offending. In terms of offences, homicide rates were in keeping with general base rates, however, sexual offences were under-represented and arson was over-represented.

In terms of reasons for offending, criminal behaviour is best described as a consequence of the classical characteristics of AS. It is suggested that despite their similarities the relationship of the two disorders with criminal behaviour may well be different. This suggestion has implications for the design of services intended to reduce the risk of offending in these two groups.

The review draws together a diverse range of literature around a rather neglected topic in criminological psychology. It will be of value to researchers in suggesting where new knowledge is needed, particularly with regard to disentangling the risk factors for offending for the two conditions, and to practitioners within the criminal justice system in pointing towards areas for intervention to reduce risk.